Over the last 30 years, a growing number of reports have described the utility of recombinant vaccinia viruses (rVACVs) expressing relevant antigens from multiple viral, bacterial, and parasitic pathogens to confer protection to immunized animals (81, (88) (89) (90) (91) (92) (93) .